Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,087 | 2,353 | 9,165 | 14,861 | 1,905 |
| Marketable Securities | 4,854 | 7,396 | 4,087 | 1,970 | 19,030 |
| Receivables | N/A | N/A | N/A | N/A | 80 |
| Other current assets | 306 | 207 | 220 | 348 | 425 |
| TOTAL | $8,603 | $10,808 | $14,211 | $17,551 | $21,984 |
| Non-Current Assets | |||||
| PPE Net | 60 | 67 | 73 | 80 | 87 |
| Other Non-Current Assets | 164 | 194 | 222 | 250 | 277 |
| TOTAL | $224 | $260 | $296 | $330 | $364 |
| Total Assets | $8,827 | $11,068 | $14,507 | $17,881 | $22,347 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,518 | 1,574 | 1,029 | 735 | 754 |
| Accrued Expenses | 2,035 | 2,508 | 2,260 | 1,858 | 1,831 |
| TOTAL | $3,705 | $4,233 | $3,439 | $2,742 | $2,733 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 26 | 58 | 90 | 121 | 150 |
| TOTAL | $26 | $58 | $90 | $121 | $150 |
| Total Liabilities | $3,730 | $4,291 | $3,529 | $2,863 | $2,883 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,464 | 6,477 | 6,477 | 6,174 | 5,348 |
| Common Shares | 7 | 7 | 6 | 5 | 5 |
| Retained earnings | -76,510 | -71,550 | -66,901 | -62,723 | -58,128 |
| Other shareholders' equity | -1 | -2 | 1 | 0 | -2 |
| TOTAL | $5,097 | $6,777 | $10,978 | $15,018 | $19,464 |
| Total Liabilities And Equity | $8,827 | $11,068 | $14,507 | $17,881 | $22,347 |